UK clinical trials - updated daily from ClinicalTrials.gov
Understand the key differences between multiple sclerosis and parkinson's disease clinical trials and research opportunities
An autoimmune demyelinating condition affecting ~130,000 people in the UK. Disease-modifying therapies are expanding rapidly, with trials for relapsing and progressive forms.
A progressive neurodegenerative condition affecting ~153,000 in the UK. Trial activity focuses on dopaminergic therapies, deep brain stimulation, and disease-modifying approaches.
MS has more active DMT trials due to clearer immune-mediated mechanisms. Parkinson's trials are more challenging due to slower progression and harder-to-measure endpoints.
Search our database of 29,000+ UK clinical trials matched to your condition and profile
Browse Disease PathwaysData sourced from ClinicalTrials.gov. Trial counts are approximate and updated regularly.
TrialConnect is a trading name of Clinical Vendor Compare Limited.
